Navigation Links
Vanda Pharmaceuticals Files Shelf Registration Statement
Date:1/31/2011

ROCKVILLE, Md., Jan. 31, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that it has filed a universal shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). Upon being declared effective by the SEC, the shelf registration statement will allow the Company to offer and sell, from time to time, up to $50 million of common stock, preferred stock, debt securities, warrants, or any combination thereof in one or more future public offerings. The actual amount and type of securities, or combination of securities, and the terms of those securities, will be determined at the time of sale, if such sale occurs. If and when a particular series of securities is offered, the prospectus supplement relating to that offering will set forth Vanda's intended use of the net proceeds received from the sale of those securities.

The filing of the shelf registration statement is designed to provide Vanda with greater flexibility to take advantage of acquisition, financing and other business opportunities when and if such opportunities arise. As of the date of this release, Vanda has no specific plans to issue securities under the shelf registration statement, and is not required to offer any securities in the future.

The shelf registration statement has not yet become effective. The securities offered by Vanda under the shelf registration statement may not be sold nor may offers to buy be accepted before the time the shelf registration statement becomes effective, nor may sales be effected in the absence of a definitive prospectus and a prospectus supplement setting forth the terms and conditions of any specific offering of securities.

This press release shall not constitute an of
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... on Omega-3 therapies for cardiovascular disease and overall health is ... accomplishments in 2014 and its outlook for 2015 from the ... Shareholders, We would like to take this opportunity ...
(Date:1/22/2015)... 22, 2015  Bio-Techne Corporation (NASDAQ: TECH ) ... member of the new Simple Plex platform through its ... represents the re-branding of the previously acquired CyPlex instrument ... is a transformative immunoassay technology which integrates an innovatively ...
(Date:1/22/2015)... Calif. , Jan. 22, 2015 Increasing sophistication ... continued consolidation of localization purchasing in 2015, says ... According to a recent study by market research firm ... a single-source solution for their translation and localization needs. ...
Breaking Medicine Technology:Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... NORFOLK, Va., Nov. 17, 2011 MedStar Health, Novant ... to reduce their supply expenses and improve operational performance. ... it has been named, represents more than $3 billion ... will work as a single entity on identified contracting ...
... Hill-Rom Holdings, Inc., (NYSE: HRC ) invites ... Piper Jaffray Health Care Conference in New York City ... You are invited to listen to the live ... or access it directly at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=HRC&item_id=4228792 .  A ...
Cached Medicine Technology:Three Large Not-for-profit Healthcare Systems Form New Supply Network 2
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... January 22, 2015 Autocarinsurancebest.com has released a ... a commercial auto insurance policy . , Auto insurance ... vehicles. It is no longer necessary to call an agent ... now available online on a single website: http://autocarinsurancebest.com/ . ...
(Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... fasciitis can lead to other problems, doctor says , WEDNESDAY, ... bring to mind tennis elbow and jogger,s knee, but the ... due to overuse, doctors warn. , The condition, plantar fasciitis, ... foot, can become chronic if steps aren,t taken to relieve ...
... ... communication with hospital administrators and doctors seeking practice opportunities. , ... Alpharetta, GA (Vocus) December 29, 2009 -- ... extending a singing holiday greeting to over 300,000 hospital administrators, physician recruiters, doctors and ...
... doctor warns , WEDNESDAY, Dec. 30 (HealthDay News) -- Skiing can ... risky, experts say. , Many skiers have learned the hard way ... trip, and the chances of getting hurt aren,t based solely on ... the U.S. Ski Association and Olympic Ski Team and an orthopedic ...
... ... Aaron Boone will be featured on January,s episode of Sharing Miracles ... and inspirational stories of real patients. Sharing Miracles airs every ... of one of only three families in history to have three generations ...
... SPRINGFIELD, Ohio, Dec. 30 AdCare Health Systems, Inc. (NYSE ... P. Gentry and Joshua J. McClellan to its Board of ... of the Board, stated that "Boyd Gentry and Josh McClellan ... care operating and financial experience. Tenwick continued, "with our ...
... small and one expert believes more research is needed , ... good as standard medication to ease hot flashes and other ... as an added bonus, the needle treatment may boost the ... "I think the data shows you that acupuncture is a ...
Cached Medicine News:Health News:Heel Pain Usually Relieved With Stretching Regimen 2Health News:Jackson & Coker Produces Online Video Holiday Message for Hospitals and Medical Providers 2Health News:Jackson & Coker Produces Online Video Holiday Message for Hospitals and Medical Providers 3Health News:If Ski Injury Occurs, Plans for Fun Go Downhill Fast 2Health News:'Sharing Miracles' Television Program to Feature Major League Baseball Star Aaron Boone 2Health News:'Sharing Miracles' Television Program to Feature Major League Baseball Star Aaron Boone 3Health News:'Sharing Miracles' Television Program to Feature Major League Baseball Star Aaron Boone 4Health News:'Sharing Miracles' Television Program to Feature Major League Baseball Star Aaron Boone 5Health News:'Sharing Miracles' Television Program to Feature Major League Baseball Star Aaron Boone 6Health News:'Sharing Miracles' Television Program to Feature Major League Baseball Star Aaron Boone 7Health News:'Sharing Miracles' Television Program to Feature Major League Baseball Star Aaron Boone 8Health News:AdCare Health Systems Names Boyd Gentry and Josh McClellan to its Board 2Health News:AdCare Health Systems Names Boyd Gentry and Josh McClellan to its Board 3Health News:Acupuncture May Cut Hot Flashes, Boost Sex Drive in Breast Cancer Patients 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: